2008

Hofmann-Apitius M, Fluck J, Furlong L, Fornes O, Kolarik C, Hanser S, Boeker M, Schulz S, Sanz F, Klinger R, Mevissen T, Gattermayer T, Oliva B, Friedrich CM. Knowledge environments representing molecular entities for the virtual physiological human. Philos Transact A Math Phys Eng Sci. 2008 Jun 17. PubMed

Furlong L.I., Dach H, Hofmann-Apitius M, Sanz F. OSIRISv1.2: a named entity recognition system for sequence variants of genes in biomedical literature. BMC Bioinformatics 2008 5;9(1):84. PubMed

Aranda R, Villalba K, Raviña E, Masaguer CF, Brea J, Areias F, Dominguez E, Selent J,  Lopez L, Sanz F, Pastor M, Loza MI. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential Antipsychotics. J Med Chem 2008; 51: 6085–94. PubMed

Selent J, López L, Sanz F, Pastor M. Multi-Receptor Binding Profile of Clozapine and Olanzapine: A Structural Study Based on the New b2 Adrenergic Receptor Template. ChemMedChem. 2008; 3:1194-98. PubMed

Stefanachi A, Brea JM, Cadavid MI, Centeno NB, Esteve C, Loza MI, Martinez A, Nieto R, Raviña E, Sanz F, Segarra V, Sotelo E, Vidal B, Carotti A. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. Bioorg Med Chem. 2008; 16(6): 2852-69. PubMed

Martínez A, Gutiérrez de Terán H, Brea J, Ravin E, Loza MI, Cadavid MI, Sanz F, Vidal B, Segarra V, Sotelo E. Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(20-furyl)-1,2,4-triazolo[1,5-a]quinoxalines. Bioorg Med Chem 2008; 16: 2103-13. PubMed